Pediatrix Medical Group (MD) Competitors $16.67 -0.34 (-2.00%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$16.65 -0.02 (-0.12%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. CRVL, AMED, AMN, CCRN, LH, DGX, DVA, CHE, BLCO, and SHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include CorVel (CRVL), Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Bausch + Lomb (BLCO), and Sotera Health (SHC). Pediatrix Medical Group vs. Its Competitors CorVel Amedisys AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics DaVita Chemed Bausch + Lomb Sotera Health Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Do institutionals & insiders hold more shares of MD or CRVL? 97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.9% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 44.6% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, MD or CRVL? Pediatrix Medical Group has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500. Comparatively, CorVel has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Do analysts rate MD or CRVL? Pediatrix Medical Group presently has a consensus price target of $16.79, suggesting a potential upside of 0.69%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MD or CRVL more profitable? CorVel has a net margin of 10.98% compared to Pediatrix Medical Group's net margin of 5.66%. CorVel's return on equity of 32.31% beat Pediatrix Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group5.66% 18.94% 7.10% CorVel 10.98%32.31%18.33% Does the media refer more to MD or CRVL? In the previous week, CorVel had 4 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 12 mentions for CorVel and 8 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.46 beat CorVel's score of 0.99 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 6 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, MD or CRVL? CorVel has lower revenue, but higher earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$2.01B0.72-$99.07M$1.2912.92CorVel$895.59M4.90$95.17M$1.9444.12 SummaryCorVel beats Pediatrix Medical Group on 9 of the 17 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.48B$7.66B$5.87B$21.68BDividend YieldN/A2.77%5.68%3.48%P/E Ratio12.9274.0174.5229.69Price / Sales0.7242.20549.7870.28Price / Cash9.6524.1437.5625.00Price / Book1.877.3512.164.58Net Income-$99.07M$238.91M$3.28B$1.00B7 Day Performance-2.26%2.63%0.87%0.65%1 Month Performance7.62%1.47%4.96%3.07%1 Year Performance52.52%16.57%60.74%14.34% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group2.3709 of 5 stars$16.67-2.0%$16.79+0.7%+54.6%$1.48B$2.01B12.924,305Positive NewsAnalyst DowngradeCRVLCorVel2.1398 of 5 stars$89.05-0.3%N/A-15.7%$4.57B$895.59M45.905,075News CoverageInsider TradeAMEDAmedisys3.2432 of 5 stars$101.01+0.0%$100.50-0.5%+4.3%$3.32B$2.40B39.3020,000AMNAMN Healthcare Services4.645 of 5 stars$20.77+3.6%$28.25+36.0%-58.3%$796.38M$2.98B-2.672,968News CoveragePositive NewsAnalyst ForecastShort Interest ↓Analyst RevisionCCRNCross Country Healthcare3.9094 of 5 stars$13.38+0.1%$17.93+34.0%-7.1%$438.36M$1.34B-51.468,205Positive NewsLHLabcorp4.6343 of 5 stars$278.07+1.0%$290.33+4.4%+26.4%$23.10B$13.01B30.6970,000Positive NewsDGXQuest Diagnostics4.7199 of 5 stars$181.81+1.5%$186.00+2.3%+18.2%$20.31B$9.87B21.7756,000Positive NewsDVADaVita4.6634 of 5 stars$137.70+1.2%$164.00+19.1%-15.6%$9.85B$12.82B13.5476,000Analyst ForecastCHEChemed4.9986 of 5 stars$458.62+1.5%$579.75+26.4%-21.6%$6.67B$2.43B23.5815,695News CoveragePositive NewsAnalyst ForecastShort Interest ↓BLCOBausch + Lomb2.0895 of 5 stars$14.63+0.6%$15.56+6.3%-2.8%$5.18B$4.79B-18.7613,500News CoveragePositive NewsSHCSotera Health2.1687 of 5 stars$16.37+1.0%$16.00-2.3%-2.6%$4.65B$1.10B204.653,000Positive NewsInsider Trade Related Companies and Tools Related Companies CRVL Competitors AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors BLCO Competitors SHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MD Stock Alerts